Risk of Neuropsychiatric Adverse Events Associated with Varenicline Treatment for Smoking Cessation among Dutch Population:A Sequence Symmetry Analysis
Purpose: Varenicline is an effective treatment for smoking cessation. While clinical trials did not confirm a causal role, case reports suggested a possible link of varenicline with neuropsychiatric adverse drug events (NPAEs). This study aims to investigate the risk of NPAEs associated with varenicline initiation among the general population in a real-world setting. Methods: We conducted a sequence symmetry analysis (SSA) based on the University of Groningen IADB.nl prescription database. We selected incident users of both varenicline and marker drugs for NPAEs, including depression, anxiety... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2022 |
Reihe/Periodikum: | Wang , Y , van Boven , J F M , Bos , J H J , Schuiling-Veninga , C C M , Boezen , H M , Wilffert , B & Hak , E 2022 , ' Risk of Neuropsychiatric Adverse Events Associated with Varenicline Treatment for Smoking Cessation among Dutch Population : A Sequence Symmetry Analysis ' , Pharmacoepidemiology and Drug Safety , vol. 31 , no. 2 , pp. 158-166 . https://doi.org/10.1002/pds.5351 |
Schlagwörter: | smoking cessation / VARENICLINE |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26671278 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/88a03d27-7e71-4c21-976a-d52b38b11f2c |